- Joined
- Nov 5, 2009
- Messages
- 14,256
- Reason
- Lost a loved one
- Diagnosis
- 00/0000
- Country
- US
- State
- WA
- City
- Seattle
I know at least one PALS around here was in this trial. It was a Phase II study planning to enroll 213 PALS. However, an independent data and safety monitoring board (DSMB) looked at the interim data, as always happens in a real trial, and recommended ending the trial because it wasn't helping, and pneumonia was occurring at a higher rate in the treated patients.
It is still on the market for several other indications, like lupus and infantile spasms, and still being tested in others.
It is still on the market for several other indications, like lupus and infantile spasms, and still being tested in others.